Skip to content
GenoLensGenoLens

SPG11

Chr 15q21.1

SPG11 vesicle trafficking associated, spatacsin

Aliases:
FLJ21439
MANE:
ENST00000261866.12

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Adult onset dystonia, chorea or related movement disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Adult onset hereditary spastic paraplegia

    BIALLELIC, autosomal or pseudoautosomal
  • Adult onset leukodystrophy

    BIALLELIC, autosomal or pseudoautosomal
  • Adult onset neurodegenerative disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset hereditary spastic paraplegia

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary neuropathy

    BIALLELIC, autosomal or pseudoautosomal

+9 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • Autosomal recessive spastic paraplegia type 11

    0.79
  • hereditary spastic paraplegia 11

    0.79
  • Charcot-Marie-Tooth disease axonal type 2X

    0.77
  • amyotrophic lateral sclerosis type 5

    0.75
  • hereditary spastic paraplegia

    0.70
  • juvenile amyotrophic lateral sclerosis

    0.60
  • hereditary disease

    0.55
  • Spastic paraplegia

    0.50
  • Abnormal central motor function

    0.49
  • metabolic disease

    0.43

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Spatacsin

May play a role in neurite plasticity by maintaining cytoskeleton stability and regulating synaptic vesicle transport

Curated MONDO disease pages that list SPG11 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.